Clinical Trial

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The success of pulpotomy treatment is affected by the type of biologically active material used.The effects of MTA and biodentine are compared in mature permanent teeth with caries exposure.It is expected that pulpotomy using biodentine will have a high success rate in caries exposed mature teeth compared to mineral trioxide aggregate.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-30.
Trial Details
NCT Number NCT06913283
Lead Sponsor Altamash Institute of Dental Medicine
Conditions Pulpitis - Irreversible
Enrollment 136 participants
Start Date 2025-05-02
Primary Completion 2025-06 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-04-24